This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...

Cancer vaccines' efficacy can be tested on an organ-on-a-chip platform that replicates age-related immune decline.

Designed with our proprietary AI-Immunology™ platform based on patient sequencing data, EVX-04 targets multiple non-conventional endogenous retrovirus (ERV) tumor antigensEVX-04 induces targeted ...

Clinicians are moving toward managing mild (Grade 1) cytokine release syndrome on an outpatient basis. The most common and ...

Bispecific antibodies bring multiple tumor-cell-killing mechanisms into play simultaneously. When a T cell is activated and ...

While type 1 and type 2 diabetes typically occupy distinct places in healthcare, research is showing an increase of patients ...

Our top picks for the best at-home COVID-19 tests include in-store and online options that are FDA-authorized for accurate results. Find the best option for your needs with our top recommendations.

Data highlights the ability of Akari’s Trop2 ADC, AKTX-101, to kill K-Ras G12V mutated cancer cell lines in preclinical ...

In the spring of 2021, the cancer field was abuzz over research that suggested a simple early-detection blood test could find ...

A new study shows that giving the chemotherapy drug cyclophosphamide after allogeneic hematopoietic cell transplantation, a curative treatment for common types of blood cancer, can make the procedure ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

The standard measure of lesion count may matter less than the underlying biology driving treatment response in ...